Marginal ulcer. Marginal corneal ulcer
Conditions
Interventions
Intervention 1: Intervention group 1: Pantoprazole 40 mg every 12 hours. Intervention 2: Intervention group 2: Pantoprazole 20 mg every 12 hours. Intervention 3: Intervention group 3: Pantoprazole 40
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with a Body Mass Index (BMI) of 40 or more Patients aged 18 to 65 years Insensitivity to pantoprazole Patients who underwent primary single anastomotic bypass surgery
Exclusion criteria
Exclusion criteria: Patients who do not want to continue the study and withdraw will be excluded from the study. Patients who are not able to continue the treatment due to special conditions at each stage of the plan. Patients who show sensitivity due to the use of pantoprazole and side effects. Patients who take aspirin, NSAIDs, corticosteroids, blood thinners, or oral anticoagulants. Patients who smoke, hookah and any tobacco. Patients who undergo a change in the prescription dose of pantoprazole due to the complication or the prescription of an antacid drug or H2 blocker at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Marginal ulcer. Timepoint: One year after surgery. Method of measurement: Endoscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Kerman Saravi
Iran University of Medical Sciences
Outcome results
None listed